Attention deficit disorders

Novel dimensional approach uncovers biomarker for inattention

Despite diagnoses for attention-deficit/hyperactivity disorder (ADHD) occurring in a reported 11 percent of U.S. school-aged kids, clinicians still don't fully understand the underlying causes of this common condition. Now ...

Neuroscience

Targeting brain chemistry to beat disease

Thanks to advances in big data and medicinal chemistry, scientists can screen thousands of molecules in the search for protein structures leading to new drugs for brain diseases.

Neuroscience

Interview with Connectomics founder Olaf Sporns

Last month marked the 10th anniversary of the landmark paper that launched "connectomics", overthrowing the predominant approach to localizing individual functions in the brain in favor of mapping the entirety of the brain's ...

page 3 from 3